EE284 Cost-Effectiveness Analysis of Larotrectinib and Entrectinib for Adult Patients with NTRK Gene Fusion-Positive Breast Cancer
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.583
https://www.valueinhealthjournal.com/article/S1098-3015(24)00698-3/fulltext
Title :
EE284 Cost-Effectiveness Analysis of Larotrectinib and Entrectinib for Adult Patients with NTRK Gene Fusion-Positive Breast Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00698-3&doi=10.1016/j.jval.2024.03.583
First page :
Section Title :
Open access? :
No
Section Order :
10067